| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5985881 | Journal of Clinical Lipidology | 2015 | 4 Pages |
Abstract
â¢We present a patient with myasthenia gravis (MG) worsened in a patient on ezetimibe.â¢We review the literature concerning lipid-modifying medications and MG.â¢Bile acid sequestrant agents may have a place in MG patients with hypercholesterolaemia.
We present a patient with myasthenia gravis (MG) who developed worsening of his condition after starting ezetimibe. We review the literature concerning lipid-modifying medications and MG.The use of bile acid sequestrant agents may have a place in the lipid management of MG patients because they did not seem to cause muscle-related side effects or worsening of MG.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sophie C. BSc, Martin A. BSc, MBBS, MA, PhD, FRCPath, FRCPI, FRCP,